macular region, compatible with a transmission defect at the level of the RPE in both eyes (Fig. 2) . A visual field test (Humphrey 30-2) failed to reveal any specific abnormality. In September 1999, in spite of the similarity of the retinal findings, his visual acuities were 6/36 in the right eye and 6/9 in the left. His CD4+ count was 450 cells/mm3 and his viral load was 36 000 RNA copies/ml. Two months later (November 1999) the macular lesions were unchanged, and despite the fact that Efavirenz had been discontinued for 5 months vision had dropped to hand movements in the left eye. 
